Feed Insights Top Reports Pricing

⌘K

06:00:00·221d

PRReleasevia Quantisnow

Dole plc Reports Third Quarter 2025 Financial Results

ByQuantisnow·Wall Street's wire, on your screen.

DOLE· Dole plc

Consumer Staples

Plus alert sent

Quantisnow Plus members were alerted at 06:00:01 ET - 1.0s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment DOLE files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DOLE (Dole plc) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Dole's Award-Winning Colada Royale Pineapple Success Fuels New Community Center in Honduras
Dole Expands Year Two of Highly Successful Global Campaign With Minecraft Designed Towards Maximum Performance With New Pineapple-Focused Experience
Director Meghen Michael John was granted 6,334 units of Ordinary Shares, increasing direct ownership by 27% to 29,617 units (SEC Form 4)
Director Toland Kevin Edward was granted 6,334 units of Ordinary Shares, increasing direct ownership by 19% to 40,478 units (SEC Form 4)
Director Tolan James Paul was granted 6,334 units of Ordinary Shares, increasing direct ownership by 21% to 36,291 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022